Clinical Trial Update: Phase 2/3 Study of KPL-387 in Recurrent Pericarditis [Phase 2, Phase 3]

View source ↗

Summary

Kiniksa's investigational drug KPL-387 is being studied in a Phase 2/3 trial for recurrent pericarditis and related conditions, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pericarditis

Drugs mentioned

• KPL-387

Snippet

Sponsor: Kiniksa Pharmaceuticals International, plc | Conditions: Pericarditis, Pericarditis Acute | Phase 2, Phase 3 | Status: RECRUITING